Increased levels of ERCC1-XPF endonuclease activity could also facilitate increased repair of cisplatin-induced ICLs by HRR during S phase, but melanoma cells show strong transcriptional downregulation of the key HRR protein RAD51 in response to cisplatin? This evidence concerns the gene ERCC4 and melanoma.